Treatment of Necrotizing Fasciitis with Documented Group A Streptococcal (Streptococcus pyogenes) Infection
Clinical scenario
This protocol applies to patients diagnosed with necrotizing fasciitis in whom Streptococcus pyogenes (group A streptococcus) has been microbiologically documented as the causative organism.
Treatment approach
Management combines surgical debridement with a targeted antibiotic combination specifically chosen for group A streptococcal infection. An alternative regimen exists for patients with severe antibiotic hypersensitivity. The complete regimen — including agents, sequencing, and hypersensitivity options — is available in the structured protocol.
Treatment goals
Clinical improvement and absence of fever for 48–72 hours.
References
DOI: 10.1093/cid/ciu296
- Penicillin plus clindamycin is recommended for treatment of documented group A streptococcal necrotizing fasciitis (strong, low).
- Necrotizing fasciitis and/or streptococcal toxic shock syndrome caused by group A streptococci should be treated with both clindamycin and penicillin.
- Penicillin should be added because of potential resistance of group A streptococci to clindamycin.
- In the absence of definitive clinical trials, antimicrobial therapy should be administered until further debridement is no longer necessary, the patient has improved clinically, and fever has been absent for 48-72 hours.
View source ↗